Pyoderma is the most common skin disease in dogs. Its welfare impact, treatment challenges, and links to antimicrobial resistance make it an important topic for responsible dog ownership and veterinary care.
Pyoderma causes significant discomfort through intense itching, pain from infected follicles and pustules, and the secondary distress of chronic skin disease. Dogs with recurrent pyoderma from uncontrolled underlying allergy live in a cycle of discomfort that profoundly affects quality of life. The overuse of antibiotics in managing pyoderma without addressing underlying causes is both a welfare failure (dogs relapse repeatedly) and an antimicrobial stewardship concern. Veterinary guidance now emphasises treating the underlying cause first, using topical antibiotics where adequate, and reserving systemic antibiotics for cases where they are genuinely needed. Early identification and management of allergic skin disease — the most common underlying driver — is the most impactful long-term welfare measure for dogs with recurrent pyoderma.